profit from every €100 of sales.

Redcare Pharmacy NV
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
It has no yearly profit to compare the price with.
of earnings would pay off all its debt.
Money in, money out
What Redcare Pharmacy NV sold, what it kept, and what it did with the cash.
Sales went from €1.20 billion in 2022 to €2.94 billion in 2025, with -€37.7 million of profit last year.
Redcare Pharmacy NV vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
Redcare Pharmacy NV | No profit yet | ||
JD Health International | 20.5× · Fair price | ||
Tsuruha Holdings | 26.6× · Fair price | ||
MatsukiyoCocokara & | 19.7× · Fair price | ||
Yifeng Pharmacy Chain | 18.4× · Fair price |
AI analysis
An AI analyst reads Redcare Pharmacy NV's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,204 | 1,799 | 2,371 | 2,941 | |
| 332 | 440 | 546 | 663 | |
| -69 | -17 | -39 | -30 | |
| -36 | 51 | 28 | 48 | |
| -78 | -12 | -46 | -38 | |
| -4.32 | -0.73 | -2.27 | -1.87 | |
| 27.5% | 24.5% | 23.0% | 22.5% | |
| -5.8% | -1.0% | -1.6% | -1.0% | |
| -6.4% | -0.7% | -1.9% | -1.3% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 729 | 1,022 | 1,003 | 1,214 |
| Cash | 67 | 84 | 97 | 92 |
| Total debt | 255 | 245 | 247 | 416 |
| Total liabilities | 375 | 470 | 493 | 735 |
| 355 | 522 | 484 | 459 | |
| 18 | 19 | 20 | 20 | |
| -8.7% | -0.6% | -3.8% | -2.2% | |
| -21.9% | -2.3% | -9.4% | -8.2% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -29 | 61 | 22 | 31 | |
| 54 | 38 | 42 | 119 | |
| -83 | 23 | -20 | -88 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 16 | 9 | 3 | 4 |
Valuation
- –
- –
- –
- 1.9×
- 0.5×
- –
- 35.3×
- -6.4%
- -2.7%
- –
Profitability
- 22.5%
- -1.0%
- -1.3%
- –
- -2.2%
- -3.8%
- –
- –
- –
- –
Growth
- +34.7%
- –
- –
- –
- +3.8%
Financial health
- 7.8×
- 0.91
- –
- -1.4×
- 1.55
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Redcare Pharmacy NV
Is Redcare Pharmacy NV a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Redcare Pharmacy NV AI analysis
What does Redcare Pharmacy NV do?
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. It is in Pharmaceutical Retailers.
Is Redcare Pharmacy NV stock halal?
Questionable. Redcare Pharmacy NV sits in a grey zone: its debt is 30% of its market value, between 30% and 33%. How we check
Who are Redcare Pharmacy NV's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Yifeng Pharmacy Chain. The peers table on this page compares their profit, growth and price with Redcare Pharmacy NV's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.



